Gossamer Bio, Inc. (GOSS)

2.74 +0.14 (+5.38%) USD  |  NASDAQ  |  Jan 21, 16:00
2.76 +0.02 (+0.73%) Pre-Market: 08:58
More

Gossamer Bio Annual EPS GAAP Estimates

Annual EPS GAAP Estimates Chart

View Annual EPS GAAP Estimates for GOSS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual EPS GAAP Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual EPS GAAP Estimates Range, Past 5 Years

View Annual EPS GAAP Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual EPS GAAP Estimates Benchmarks

View Annual EPS GAAP Estimates Benchmarks
Start Trial
Madrigal Pharmaceuticals, Inc. Upgrade
XOMA Royalty Corp. Upgrade
Rezolute, Inc. Upgrade
Axsome Therapeutics, Inc. Upgrade
Crinetics Pharmaceuticals, Inc. Upgrade